Search results
7 mar 2022 · There is a single randomized trial evaluating standard surgical excision vs. radiotherapy for facial BCCs < 4 cm, in 347 patients. The 4-year actuarial failure rate was 0·7% (95% confidence interval 0·1–3·9%) for surgery, and 7·5% (95% confidence interval 4·2–13·1%) for radiotherapy (P = 0·003).
13 lip 2023 · The present guidelines contain recommendations regarding diagnosis, therapy, and follow-up of patients with BCC, addressing in detail all aspects of BCC management, from the common types of tumours to those which are ‘difficult-to-treat’ or ‘advanced.’
10 sty 2018 · In these evidence-based guidelines of care, we provide recommendations for the management of patients with BCC, as well as an in-depth review of the best available literature in support of these recommendations.
1 lis 2021 · The overall objective of the guideline is to provide up‐to‐date, evidence‐based recommendations for the management of basal cell carcinoma (BCC). The document aims to: Offer an appraisal of all relevant literature up to 24 January 2020, focusing on any key developments.
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023. Eur J Cancer. 2023 Oct:192:113254. doi: 10.1016/j.ejca.2023.113254. Epub 2023 Jul 28. Authors.
18 cze 2019 · Topical therapies (5% imiquimod, 5% fluorouracil) and destructive approaches (curettage, electrocautery, cryotherapy, laser ablation) should be considered in patients with low-risk superficial BCC. Photodynamic therapy is an effective treatment for superficial BCC and thin nodular BCC.
When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly curative. In these evidence-based guidelines of care, we provide recommendations for the management of patients with BCC, as well as an in-depth review of the best available literature in support of these recommendations.
